Contract awardedRemote patient monitoring and virtual ward technology

Huma Therapeutics supplies GDm-Health to Birmingham Women's and Children's

Birmingham Women's and Children's NHS Foundation Trust is paying Huma Therapeutics for a year's subscription to GDm-Health. The software lets the trust's clinicians monitor patients with gestational diabetes remotely, with their data brought together for clinical review.

The trust awarded the £12,500 subscription directly in April 2026, without a competition. It runs to April 2027.

Alert me to similar tenders

Contract ends April 2027

What
Remote patient monitoring and virtual ward technology
Value
£12,500
How it was bought
Below threshold - without competition
Dates and next
Apr 2026 to Apr 2027

How it was bought

1 official notice
  1. 20 Apr 2026Contract starts
  2. 2 Jun 2026Award noticeFind a Tender
  3. 20 Apr 2027Contract ends

How it compares

With every remote patient monitoring and virtual ward technology award since 2021

Half of awards fall between £40,637 and £268,903Median £106,000

Awards
91
Firms that won them
35
Median award
£106,000
of 86 with a value
This award
Smaller than 97%
of them
Typical length
1 year
In West Midlands
6 awards

Huma Therapeutics Limited ranks 2nd of 35 firms for remote patient monitoring and virtual ward technology awards since 2021.

RankFirmAwardsValue
1Locked18£13m
2Locked7£849,890
2Huma Therapeutics Limited Won this one7£192,530
4Locked5£2.49m
5Locked4£973,750
5Locked4£795,265
See who wins this work

Figures to 21 November 2026

Remote patient monitoring and virtual ward technology at other buyers

Birmingham Women's and Children's NHS Foundation Trust has awarded 312 contracts since 2021.

See Birmingham Women's and Children's NHS Foundation Trust's page
  • Huma Therapeutics Limited has won 9 public contracts since 2021.

4 remote patient monitoring and virtual ward technology tenders are open now

See them
More remote patient monitoring and virtual ward technology contracts awarded in 2026